LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer

Author(s):  Kramer Mark A, Grilley Bambi J

Issue:  Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Abstract:  

Related Keywords: Investigational drugs, gaining access to, New drug application, a primer for

Related Categories: LEGAL, SUPPORT, FDA

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Kramer Mark A, Grilley Bambi J Jul/Aug 2002 271-273 Buy
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A Nov/Dec 2011 526-527 Buy
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W May/Jun 2016 202-206 Buy
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr Jul/Aug 2007 350-351 Buy
Disposing of Expired Drugs and Chemicals: New Options for Compounders Vail Jane Jan/Feb 2008 38-47 View Sample
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A Sep/Oct 2009 400-403 Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake Sep/Oct 2015 377-380 Buy
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A Jul/Aug 2012 294-298 Buy
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna Nov/Dec 2012 456-460 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample